Clinical trials

Moximed is committed to rigorous clinical evaluation of the Atlas Knee System


Moximed is committed to validating its implantable, extra-capsular joint unloading technology in multiple clinical trials. More than 400 subjects were treated in five clinical trials of the previous generation KineSpring® System. The clinical experience gained since the first implant in 2008 has proven Moximed’s concept of an implantable joint unloading system.


Phantom Feasibility Study

The Atlas Knee System design was first evaluated in the Phantom Clinical Trial – a 40 patient, prospective, multi-center, single-arm study. Enrollment at four clinical study sites is complete, and patients are currently in the follow-up phase.


US Atlas IDE Study


EU Atlas Post-Market Study

The EU Atlas Post-Market Study is a post-approval, prospective, multi-center, single-arm study of the Atlas Knee System.